Serial placental growth factor-based testing in pre-eclampsia

Affiliations

¹ Fetal Maternal Medicine Unit, Queen Charlotte's and Chelsea Hospital, London, UK; Nuffield Department of Women's Health and Reproductive Research, University of Oxford, Oxford OX3 9DU, UK. Electronic address: sofia.cerdeira@wrh.ox.ac.uk.
² Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Comment

Ana Sofia Cerdeira et al. Lancet. 2024.

. 2024 Feb 17;403(10427):588-589.

doi: 10.1016/S0140-6736(23)02578-3. Epub 2024 Feb 8.

¹ Fetal Maternal Medicine Unit, Queen Charlotte's and Chelsea Hospital, London, UK; Nuffield Department of Women's Health and Reproductive Research, University of Oxford, Oxford OX3 9DU, UK. Electronic address: sofia.cerdeira@wrh.ox.ac.uk.
² Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

No abstract available

Comment on

Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial.
Hurrell A, Webster L, Sparkes J, Battersby C, Brockbank A, Clark K, Duhig KE, Gill C, Green M, Hunter RM, Seed PT, Vowles Z, Myers J, Shennan AH, Chappell LC; PARROT-2 trial group. Hurrell A, et al. Lancet. 2024 Feb 17;403(10427):619-631. doi: 10.1016/S0140-6736(23)02357-7. Epub 2024 Feb 8. Lancet. 2024. PMID: 38342128 Clinical Trial.